Skip to content

The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients

The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients, Special Relevance to Atherosclerosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00155922
Enrollment
100
Registered
2005-09-12
Start date
2003-11-30
Completion date
Unknown
Last updated
2006-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Diabetes Mellitus, Type 2

Keywords

Diabetes mellitus, Monocyte, Gene expression, Monocyte gene expression

Brief summary

The investigators hypothesize that macrophages play a crucial role in the pathogenesis of atherosclerosis in patients with type 2 diabetes mellitus (T2DM).

Detailed description

Cardiovascular events are the leading cause of death in developed countries worldwide, including Taiwan. Type 2 diabetes mellitus (T2DM), previously considered merely as one of the risk factors, has been recently unanimously accepted to be coronary artery disease-equivalent. How T2DM may lead to accelerated atherosclerosis remains obscure. Hyperglycemia with or without hyperinsulinemia may lead to higher oxidative stress and generalized inflammation. The oxidative stress and inflammation may play a significant role in the pathogenesis in diabetic complications, including micro- and macro-vascular complications. Macrophages together with T-lymphocytes are the earliest cell-types found in fatty-streaks, the earliest atherosclerotic lesions. Macrophages are also well known cellular mediators of oxidative stress and inflammation. Therefore, it is plausible to hypothesize that macrophages play a crucial role in the pathogenesis of atherosclerosis in patients with T2DM. In addition, the other cell types of the peripheral white blood cells (WBC), such as neutrophils, have been shown to be intimately related to acute coronary syndrome. Therefore, the study on the biology of peripheral WBCs may tell us something about the pathophysiology of diabetic macro-vascular complications. Methods: 1. Normal control: fasting plasma glucose (FPG) less than 126 mg/dl. 2. T2DM: FPG \>=126 mg/dl. * Group 1 (good glycemic control): hemoglobin A1c (HbA1c) \<= 7% in the past 6 months * Group 2 (poor glycemic control): HbA1c \>= 8% in the past 6 months 3. Blood sample will be collected at baseline and after aggressive control.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal control: fasting plasma glucose (FPG) less than 126 mg/dl. * T2DM: FPG \>=126 mg/dl. * Group 1 (good glycemic control): HbA1c\<=7% in the past 6 months * Group 2 (poor glycemic control): HbA1c\>=8% in the past 6 months

Exclusion criteria

* Acute systemic diseases

Countries

Taiwan

Contacts

Primary ContactWei-Shiung Yang, MD, PhD
wsyang@ha.mc.ntu.edu.tw886-2-2312-3456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026